For: | Nonaka K, Fujioka H, Takii Y, Abiru S, Migita K, Ito M, Kanematsu T, Ishibashi H. mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC. World J Gastroenterol 2010; 16(38): 4846-4853 [PMID: 20939114 DOI: 10.3748/wjg.v16.i38.4846] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i38/4846.htm |
Number | Citing Articles |
1 |
Qing Pang, Kai Qu, Jian-Bin Bi, Su-Shun Liu, Jing-Yao Zhang, Si-Dong Song, Ting Lin, Xin-Sen Xu, Yong Wan, Ming-Hui Tai, Hao-Chen Liu, Ya-Feng Dong, Chang Liu. Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis. World Journal of Gastroenterology 2015; 21(25): 7895-7906 doi: 10.3748/wjg.v21.i25.7895
|
2 |
Hui-Hua Chang, Emmanuelle J Meuillet. Identification and Development of Mpges-1 Inhibitors: Where We are At?. Future Medicinal Chemistry 2011; 3(15): 1909 doi: 10.4155/fmc.11.136
|
3 |
Malkeet Singh Bahia, Yogesh Kumar Katare, Om Silakari, Bhawna Vyas, Pragati Silakari. Inhibitors of Microsomal Prostaglandin E2 Synthase‐1 Enzyme as Emerging Anti‐Inflammatory Candidates. Medicinal Research Reviews 2014; 34(4): 825 doi: 10.1002/med.21306
|
4 |
Chao Chen, Jun Guan, Xinyu Gu, Qingfei Chu, Haihong Zhu. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.834859
|
5 |
Puneet Khurana, Sanjay M. Jachak. Chemistry and biology of microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors as novel anti-inflammatory agents: recent developments and current status. RSC Advances 2016; 6(34): 28343 doi: 10.1039/C5RA25186A
|
6 |
Dimitrios Kotsos, Konstantinos Tziomalos. Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3): 3049 doi: 10.3390/ijms24033049
|
7 |
Delong Xu, Jie Cai, Zhi-kang Wan, Hang Gao, Ying Sun. Pathophysiological role of prostaglandin E synthases in liver diseases. Prostaglandins & Other Lipid Mediators 2021; 154: 106552 doi: 10.1016/j.prostaglandins.2021.106552
|
8 |
Zhaohui Zhang, Yi Zhang, Wei Wang, Yunpeng Hua, Linyun Liu, Shunli Shen, Baogang Peng. Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis. Journal of Surgical Research 2017; 210: 99 doi: 10.1016/j.jss.2016.11.002
|
9 |
Mario M. Alba, Brandon Ebright, Brittney Hua, Ielyzaveta Slarve, Yiren Zhou, Yunyi Jia, Stan G. Louie, Bangyan L. Stiles. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1098467
|